![]() Trump administration limits research using fetal tissue The federal government cannot stop private industry from using fetal tissue and Regeneron supports its use. The US Department of Health and Human Services has stopped the National Institutes of Health from obtaining any more fetal tissue for research and has set up a board that has virtually stopped it from funding any academic groups that use it. People against abortion rights oppose both uses, as does the Trump administration. In the past, this tissue was also sometimes taken from abortions. They’re left over from when couples make extra fertilized eggs and then do not need them. Trump is blocking vital biomedical researchĮspecially involved are human embryonic stem cells, made using days-old embryos, usually taken from fertility clinics. AFP PHOTO / SAUL LOEB (Photo credit should read SAUL LOEB/AFP/Getty Images) Saul Loeb/AFP/Getty Images Hinrichs' approach focuses on HPV tumors because they contain viral antigens that the immune system can easily recognize. But many common cancers lack this clear, surface signal. Immunotherapies that have seen widespread success, such as chimeric antigen receptor (CAR-T) cell therapies, mainly target blood cancers like lymphoma, myeloma and leukemia, which have a tumor antigen - like a flag or a signal - on the surface of the cells so it is easy for immune cells to find and target the harmful cells. A person's T-cells will naturally try to kill off any invader, including cancer, but usually fall short because tumors can mutate, hide, or simply overpower the immune system. Christian Hinrichs, an investigator at the National Cancer Institute at the National Institutes of Health (NIH) in Bethesda, Maryland, February 7, 2018.Įxperimental trials are ongoing at the National Institutes of Health Clinical Center, a US government-funded research hospital where doctors are trying to partially replace patients' immune systems with T-cells that would specifically attack cancers caused by the human papillomavirus (HPV), a common sexually transmitted infection. Benjamin Jin, a biologist working on immunotherapy for HPV+ cancers, holds test tubes as he works in the lab of Dr. Trump’s base, of course, is strongly against abortion rights and his administration acted quickly to reverse many Obama era policies – including policies that moved forward scientific research involving human fetal tissue.ĭr. Regeneron’s therapy indirectly relied on tissue taken from an abortion. It has to do with abortion politics, and the science of using human tissue to test and to make medicines. Trump's endorsement sends Regeneron and Eli Lilly stocks rising (David Morrison/Eli Lilly via AP) David Morrison/AP ![]() Its drug is similar to one that President Donald Trump received on Friday, Oct. 7 in a news release they have not yet been published or reviewed by independent scientists. Eli Lilly and Company announced the partial results Wednesday, Oct. government to allow emergency use of an experimental antibody therapy based on early results from a study suggesting the drug reduced symptoms, the amount of virus and hospitalizations and ER visits for patients with mild or moderate COVID-19. The drug company says it has asked the U.S. In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |